Homogeneous human interleukin 2
US5597901A · kind A · utility
19Cited by
2References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 25, 1995 |
| Grant date | Jan 28, 1997 |
| Priority date | — |
| Expiry date | May 25, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/141
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Human interleukin 2 (IL-2) derived from induced human malignant cells has been purified to homogeneity using multiple high performance liquid chromatography (HPLC) steps. The purified IL-2 exhibits potent activity promoting the long-term in vitro culture of antigen-specific effector T-lymphocytes and in modulating lymphocyte reactivity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.